Form S-1
We note your statement that your market share and market position information is an approximation based upon management’s knowledge. Please further describe the basis of management’s knowledge that support your statements in the prospectus summary that you have outperformed the market in winning clients among financial institutions that emphasize retail banking and that you are one of the fastest-growing digitalRest of the question
banking platforms in the United States.
No reply letter found.
Please present financial and operational metrics for each period presented to provide sufficient context and balance to the disclosures. In this regard, you disclose net dollar revenue retention rate only for nine-months ended September 30, 2020 and the number of clients for fiscal 2020 but do not provide similar disclosure for fiscal 2019.
No reply letter found.
Please define how you calculate net dollar revenue retention rate. Our Industry, page 4
No reply letter found.
Please identify the industry source supporting your statement that there are over 350 million digital bank user accounts in the United States and the retail analytics firm that stated foot traffic remained down nearly 25% year-over-year for the week ended November 29, 2020.
No reply letter found.
Please disclose any material assumptions and limitations associated with your estimate of your total addressable market as addressed in the FI Navigator report. For example, one material limitation on the expected growth of your total addressable market would be the trend of consolidation among financial institutions and that very few new financial institutions are being created.
No reply letter found.
Please disclose the amount outstanding under your credit agreement. Anti-takeover provisions contained in our charter documents…, page 40
No reply letter found.
Please briefly describe those provisions in your amended and restated certificate of incorporation that require a 66 2/3% vote to repeal.
No reply letter found.
Please quantify the beneficial ownership of your executive officers, directors and principal stockholders.
No reply letter found.
Please revise this risk factor to discuss the specific impacts of COVID-19 on the company or advise.
No reply letter found.
We note your disclosure on page 67 that you believe non-GAAP cost of subscription services provides investors and other users of your financial information consistency and comparability with your past financial performance and facilitates period-to-period comparisons of operations. Please further clarify why this measure provides useful information to investors.Rest of the question
In this regard, it appears to exclude significant expenses that are necessary to generate your subscription revenues. Refer to Item 10 (e) of Regulation S-K.
No reply letter found.
Clarify why it is appropriate to refer to this measure as non-GAAP cost of subscription revenue, which is a similar description to GAAP cost of revenues, and it excludes significant implementation services expenses that are necessary to generate your subscription revenues. Refer to Item 10(e) of Regulation S-K.
No reply letter found.
Please disclose the source of the statistical information presented in this section. Executive Compensation, page 115
No reply letter found.
Please provide executive compensation disclosure for the year ended December 31, 2019. In this regard, we note that executive compensation disclosure for the year ended December 31, 2019 is required to be included in your registration statement as that information previously was required to be provided in response to a Commission filing requirement. Refer to Instruction 1 to Item 402(c) of Regulation S-K.
No reply letter found.
Please file the agreement with CU cooperative as an exhibit to your registration statement. Refer to Item 601(b)(10)(ii)(A) of Regulation S-K.
No reply letter found.
Please disclose the exceptions to the lock-up agreements.
No reply letter found.
You disclose that implementation and integration of the digital banking platform is complex, and you have determined that the one-time, upfront services do not transfer a promised service to the client. Please further clarify the nature of your implementation services and why they are not distinct from your SaaS services.Rest of the question
Tell us how you considered the factors in ASC 606-10-25-19 through ASC 606-10-25-21 in making your determination.
No reply letter found.
Please clarify when you begin to recognize revenue relating to your SAAS arrangements. Clarify if you begin to recognize revenue upon commencement of the implementation services or when the customer goes live on your platform, and the basis for this
No reply letter found.
You disclose that for those services that are processed by third party applications you evaluate whether you are acting as a principal or an agent based upon the transfer of control of the services to the customer and after evaluating each of the applications used to provide SaaS services, you have determined that you are acting as the principal in these transactions and record revenue on a gross basis.Rest of the question
Please further clarify the nature of the services that are processed by third party applications and how you considered each of the factors in ASC 606-10-55-36 through 55-40.
No reply letter found.
Tell us how you considered your recent sales of preferred shares in the determination of the fair value of your common stock.
No reply letter found.
Please clarify your disclosure to state whether all of your redeemable convertible preferred shares are convertible upon a qualified IPO, and describe how a qualified IPO is defined.
No reply letter found.
Please disclose the fair value of your shares of common stock used in the determination of the fair value of your stock options for each period presented.
No reply letter found.
Please provide your significance test for the acquisition of ACH Alert. We refer you to Rule 3-05 of Regulation S-X. Based on the significance please provide the required audited financial statements and pro forma information as required by Article of 11 of Regulation S-X.
No reply letter found.
Please supplementally provide us with copies of all written communications, as defined in Rule 405 under the Securities Act, that you, or anyone authorized to do so on your behalf, present to potential investors in reliance on Section 5(d) of the Securities Act, whether or not they retain copies of the communications.
No reply letter found.
Balance your presentation of selected financial information by including equally prominent disclosure of your increasing net loss position over the last three years. In addition, please confirm that all the individuals providing testimonials have consented to the inclusion of their testimonials in your filing.
The Company respectfully acknowledges the Staff’s comment and will revise the graphics on page i in the next amendment to the Registration Statement accordingly. In particular, the Company will remove the selected financial information previously included. The Company also respectfully advises the Staff that all the individuals providing testimonials have consented to the inclusion of their testimonials in the Company’s filing.Read in the reply
Your response dated March 22, 2021 indicates that you issued 2.7 million options subsequent to December 31, 2020. Considering the proximity of these issuances to the date your preliminary price range was determined tell us how you considered using the preliminary price range as a factor in determining the fair value of your common stock on these issuance dates.Rest of the question
In this regard, please quantify factors that supports the significant difference between the 2021 grants valuation and the Preliminary Assumed IPO price. Tell us whether changes in revenue and operating results supports this significant increase in valuation within a short time frame. In addition, clarify whether additional disclosure is warranted since it appears that the rapid changes in valuation of your shares of ordinary shares was not solely attributable to changes in your financial condition or results of operations.
The Company respectfully acknowledges the Staff’s comment. The Company has historically determined the fair value of its common stock using methodologies, approaches and assumptions consistent with the American Institute of Certified Public Accountants Accounting andRead in the reply
Valuation Guide, Valuation of Privately-Held-Company Equity Securities Issued as Compensation (the “AICPA Practice Guide”).Rest of the answer
In addition, the Company’s Board of Directors also considered numerous objective and subjective factors, along with input from management and third-party valuations, to determine the fair value of the Company’s common stock as disclosed in the Registration Statement.
Option grants on February 5, 2021, February 10, 2021 and February 25, 2021 (collectively, the “2021
Grants”) occurred while uncertainty continued to exist regarding market reception to the Company’s proposed initial public offering (“IPO”) as well as overall performance of equity markets and the level of demand for IPOs in general. As a result, the Company approached the valuations underlying the 2021 Grants similar to past practice by engaging an independent third-party valuation firm and assessing the Company’s likelihood for completing an IPO as well as other factors. Pursuant to this process, the Company determined the fair value per share of its common stock to be $15.46, $15.46 and $18.62 when issuing stock option grants on February 5, 2021, February 10, 2021 and February 25, 2021, respectively. This implied a fair market value of the Company equity of $1.5 billion, $1.5 billion and $1.7 billion for these dates.
On March 23, 2021, the Company established an initial price range for its IPO of $26 to $29 (slightly lower on the high end than communicated in the Company’s letter to the Staff dated March 22, 2021). At the midpoint of the range, the price per share would be $27.50 and the implied fair market of value of the Company’s equity would be $2.45 billion. The increase in the projected value of the Company’s equity from the valuations used for the 2021 Grants resulted primarily from information gathered from ongoing “testing the water meetings,” continued investor feedback from prior “testing the water meetings” following the Company’s public filing of its registration statement on Form
S-1 on March 10, 2021, and the advice of the Company’s financial advisors regarding the Company’s IPO prospects.
The Company acknowledges that, even though its valuations underlying the 2021 Grants were made in good faith based on standard methodologies and assumptions, in light of the difference between the fair value for a share of its common stock used for stock options granted in February 2021 and the initial price range established for its IPO, the Company reassessed the fair value of these grants in order to determine the appropriate stock-based compensation expense for financial reporting purposes based on a straight-line interpolation from its valuation prepared for December 31, 2020 and the mid-point of its initial price range established for its IPO. Therefore, the Company notes that while it has not yet prepared financial statements for this period, when it does so it intends, solely for financial reporting purposes, to determine the stock-based compensation expense for the 2021 Grants using a fair value per share of its common stock of $20.46, $21.03 and $22.73 for the option grants issued February 5, 2021, February 10,
2021 and February 25, 2021, respectively. As a result, the Company estimated the grant-date fair value of the 2021 Grants to be approximately $25.5 million, which is expected to be recognized, net of estimated forfeitures, over a requisite service period of 4 years.
The Company correspondingly proposes to update the following disclosure in Note 17, Subsequent Events, to its financial statements, regarding the 2021 Grants as follows:
On February 5, 2021 and February 10, 2021, following approval by the
Company’s board of directors, the Company issued options to purchase an aggregate of 2.4 million shares of the Company’s common stock, with an exercise price of $15.46 on the grant date to employees under the 2011 Plan. The stock option grants expire in ten years. Of the stock options, 0.2 million vest 25% after one year and then monthly prospectively for a three-year period with the remaining 2.2 million stock options vesting monthly over a four-year period in 48 equal monthly installments. In order to determine the appropriate stock-based compensation expense for financial reporting purposes, the Company utilized a fair value per share of its common stock as of the date of the awards to $20.46 and $21.03, respectively. The grant-date fair value of the stock options granted on February 5, 2021 and February 10, 2021 is approximately $22.1 million, which is expected to be recognized, net of estimated forfeitures, over a requisite service period of 4 years.
On February 25, 2021, following approval by the Company’s board of directors, the
Company issued options to purchase an aggregate of 0.3 million shares of the Company’s common stock, with an exercise price of $18.62 on the grant date to employees under the 2011 Plan. The stock option grants expire in ten years. The stock options generally vest 25% after one year and then monthly prospectively for a three-year period. In order to determine the appropriate stock-based compensation expense for financial reporting purposes, the Company utilized a fair value per share of its common stock as of the date of the awards to $22.73. The grant-date fair value of the stock options granted on February 25, 2021 is approximately $3.4 million, which is expected to be recognized, net of estimated forfeitures, over a requisite service period of generally 4 years.
The Company correspondingly proposes to update the following disclosure in
“Management’s Discussion and Analysis of Results of Financial Condition and Results of Operations – Critical Accounting Policies and Estimates – Stock Based Compensation”, regarding the 2021 Grants as follows:
Preliminary Offering Price and Options Granted Subsequent to December 31, 2020
During February 2021 we granted stock options to purchase up to 2.7 million shares of our common stock at a weighted average price of
$15.87 per share which generally vest over a requisite service period of generally 4 years. In light of the difference between the fair value for a share of our common stock used for stock options granted in February 2021 and the initial price range set forth on the cover page of this prospectus, we established the fair value of these grants based on a straight-line interpolation from our December 31, 2020 valuation and the mid-point of our initial price range in order to determine the appropriate stock-based compensation expense for financial reporting purposes. Therefore, we note that while we have not yet prepared financial statements for this period, when we do we intend, solely for financial reporting purposes, to use an estimated grant-date fair value of $25.5 million for the February 2021 Grants, which is expected to be recognized, net of estimated forfeitures, over a requisite service period of generally 4 years. Our estimates are based upon information currently available and could change as events and circumstances change.
Upon completion of this offering, our common stock will be publicly traded and we will rely on the closing price of our common stock as reported on the date of grant to determine the fair value of our common stock.
Please revise Exhibits 3.2 and 3.4 to clarify that the exclusive forum provision does not apply to claims under the Exchange Act.
The Company respectfully acknowledges the Staff’s comment and will revise Exhibits 3.2 and 3.4 in the next amendment to the Registration Statement accordingly.Read in the reply